Literature DB >> 11325885

Polymorphic short tandem repeats for diagnosis of the Charcot-Marie-Tooth 1A duplication.

P Latour1, L Boutrand, N Levy, R Bernard, A Boyer, F Claustrat, G Chazot, M Boucherat, A Vandenberghe.   

Abstract

BACKGROUND: A 1.5-Mb microduplication containing the gene for peripheral myelin protein 22 (PMP22) on chromosome 17p11.2-12 is responsible for 75% of cases of the demyelinating form of Charcot-Marie-Tooth disease (CMT1A). Methods for molecular diagnosis of CMT1A use Southern blot and/or amplification by PCR of polymorphic poly(AC) repeats (microsatellites) located within the duplicated region, or the detection of junction fragments specific for the duplication. Difficulties with both strategies have led us to develop a new diagnostic strategy with highly polymorphic short tandem repeats (STRs) located inside the CMT1A duplicated region.
METHODS: We tested 10 STRs located within the duplication for polymorphic behavior. Three STRs were selected and used to test a set of 130 unrelated CMT1A patients and were compared with nonduplicated controls. The study was then extended to a larger population of patients. Alleles of interest were sequenced. A manual protocol using polyacrylamide electrophoresis and silver staining and an automated capillary electrophoresis protocol to separate fluorescently labeled alleles were validated.
RESULTS: We identified three new STRs covering 0.55 Mb in the center of the CMT1A duplication. One marker, 4A, is located inside the PMP22 gene. The two others, 9A and 9B, more telomerically positioned, have the highest observed heterozygosity reported to date for CMT1A markers: 0.80 for 9A, and 0.79 for 9B. Tetra- and pentanucleotide repeats offered clear amplification, accurate sizing, and easy quantification of intensities.
CONCLUSIONS: Combined use of the three STRs allows robust diagnosis with almost complete informativeness. In our routine diagnosis for CMT1A, they have replaced the use of other polymorphic markers, either in a manual adaptation or combined with fluorescence labeling and allele sizing on a DNA sequencer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11325885

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  11 in total

1.  Differential expression of E-cadherin, β-catenin, and Lewis x between invasive hydatidiform moles and post-molar choriocarcinomas.

Authors:  Jean-Jacques Candelier; Lucien Frappart; Ange Lucien Diatta; Tarik Yadaden; Mamadou-Lamine Cissé; Jean-Marie Afoutou; Jean-Yves Picard; Benoît Mennesson; Rima Slim; Karim Si-Tayeb; Philippe Coullin
Journal:  Virchows Arch       Date:  2013-05-17       Impact factor: 4.064

2.  Characteristics of demyelinating Charcot-Marie-Tooth disease with concurrent diabetes mellitus.

Authors:  Zhiliang Yu; Xiaohua Wu; Huijun Xie; Ying Han; Yangtai Guan; Yong Qin; Huimin Zheng; Jianming Jiang; Zhenmin Niu
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

3.  Altered p16 and Bcl-2 expression reflects pathologic development in hydatidiform moles and choriocarcinoma.

Authors:  Jean-Jacques Candelier; Lucien Frappart; Tarik Yadaden; Henriette Poaty; Jean-Yves Picard; Sophie Prévot; Philippe Coullin
Journal:  Pathol Oncol Res       Date:  2012-10-13       Impact factor: 3.201

Review 4.  Intraneural perineurioma affecting multiple nerves: a case report and literature review.

Authors:  Lei-Ming Wang; Yan-Feng Zhong; Dan-Feng Zheng; A-Ping Sun; Ying-Shuang Zhang; Rong-Fang Dong; Yi Pan
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

5.  A rapid and reliable detection system for the analysis of PMP22 gene dosage by MP/DHPLC assay.

Authors:  Chia-Yun Lin; Yi-Ning Su; Chien-Nan Lee; Chia-Cheng Hung; Wen-Fang Cheng; Win-Li Lin; Chi-An Chen; Sung-Tsang Hsieh
Journal:  J Hum Genet       Date:  2006-02-04       Impact factor: 3.172

6.  Gap junction beta 1 (GJB1) gene mutations in Italian patients with X-linked Charcot-Marie-Tooth disease.

Authors:  Paola Mandich; Marina Grandis; Alessandro Geroldi; Massimo Acquaviva; Alessandra Varese; Rossella Gulli; Paola Ciotti; Emilia Bellone
Journal:  J Hum Genet       Date:  2008-04-01       Impact factor: 3.172

7.  Mechanism, prevalence, and more severe neuropathy phenotype of the Charcot-Marie-Tooth type 1A triplication.

Authors:  Pengfei Liu; Violet Gelowani; Feng Zhang; Vivian E Drory; Shay Ben-Shachar; Erin Roney; Adam C Medeiros; Rebecca J Moore; Christina DiVincenzo; William B Burnette; Joseph J Higgins; Jun Li; Avi Orr-Urtreger; James R Lupski
Journal:  Am J Hum Genet       Date:  2014-02-13       Impact factor: 11.025

8.  Genome-wide high-resolution aCGH analysis of gestational choriocarcinomas.

Authors:  Henriette Poaty; Philippe Coullin; Jean Félix Peko; Philippe Dessen; Ange Lucien Diatta; Alexander Valent; Eric Leguern; Sophie Prévot; Charles Gombé-Mbalawa; Jean-Jacques Candelier; Jean-Yves Picard; Alain Bernheim
Journal:  PLoS One       Date:  2012-01-09       Impact factor: 3.240

9.  Rapid genetic screening of Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies patients.

Authors:  Xiaobo Li; Xiaohong Zi; Lin Li; Yajing Zhan; Shunxiang Huang; Jin Li; Xuning Li; Xigui Li; Zhengmao Hu; Kun Xia; Beisha Tang; Ruxu Zhang
Journal:  Neural Regen Res       Date:  2012-11-15       Impact factor: 5.135

10.  Mutation spectrum of Charcot-Marie-Tooth disease among the Han Chinese in Taiwan.

Authors:  Yun-Hsin Hsu; Kon-Ping Lin; Yuh-Cherng Guo; Yu-Shuen Tsai; Yi-Chu Liao; Yi-Chung Lee
Journal:  Ann Clin Transl Neurol       Date:  2019-05-27       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.